Literature DB >> 20640425

SUMO mediating fusion expression of antimicrobial peptide CM4 from two joined genes in Escherichia coli.

Jian Feng Li1, Jie Zhang, Zhen Zhang, Chun Tao Kang, Shuang Quan Zhang.   

Abstract

Antibacterial peptide CM4 (ABP-CM4) is a small cationic peptide with broad-spectrum activities against bacteria, fungi, and tumor cells, which may possibly be used as an antimicrobial agent. To improve the expression level of CM4 in Escherichia coli, two tandem repeats of CM4 genes were cloned into the vector pSUMO to construct an expression vector pSUMO-2CM4. The fusion protein SUMO-2CM4, purified by Ni(2+)-chelating chromatography, was cleaved by hydroxylamine hydrochloride to release recombinant CM4. After the cleaved sample was re-applied to a Ni-IDA column, finally, about 48 mg recombinant CM4 was obtained from 1 L bacterial culture with no less than 96% purity, which was the highest yield of CM4 reported so far.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640425     DOI: 10.1007/s00284-010-9705-3

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  11 in total

1.  Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes.

Authors:  B L Kagan; M E Selsted; T Ganz; R I Lehrer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Ultrashort antibacterial and antifungal lipopeptides.

Authors:  Arik Makovitzki; Dorit Avrahami; Yechiel Shai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

3.  High-level production of bioactive human beta-defensin-4 in Escherichia coli by soluble fusion expression.

Authors:  Zhinan Xu; Zhixia Zhong; Lei Huang; Li Peng; Fang Wang; Peilin Cen
Journal:  Appl Microbiol Biotechnol       Date:  2006-01-20       Impact factor: 4.813

4.  Expression of a cytotoxic cationic antibacterial peptide in Escherichia coli using two fusion partners.

Authors:  Yu Qing Chen; Shuang Quan Zhang; Bao Cun Li; Wen Qiu; Bo Jiao; Jie Zhang; Zhen Yu Diao
Journal:  Protein Expr Purif       Date:  2007-10-01       Impact factor: 1.650

5.  TrxA mediating fusion expression of antimicrobial peptide CM4 from multiple joined genes in Escherichia coli.

Authors:  Liangfan Zhou; Zhihui Zhao; Baocun Li; Yufeng Cai; Shuangquan Zhang
Journal:  Protein Expr Purif       Date:  2008-12-03       Impact factor: 1.650

Review 6.  Avian antimicrobial peptides: the defense role of beta-defensins.

Authors:  Haryadi Sugiarto; Pak-Lam Yu
Journal:  Biochem Biophys Res Commun       Date:  2004-10-22       Impact factor: 3.575

7.  Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification.

Authors:  T Moks; L Abrahmsén; E Holmgren; M Bilich; A Olsson; M Uhlén; G Pohl; C Sterky; H Hultberg; S Josephson
Journal:  Biochemistry       Date:  1987-08-25       Impact factor: 3.162

Review 8.  Antibacterial peptides: basic facts and emerging concepts.

Authors:  H G Boman
Journal:  J Intern Med       Date:  2003-09       Impact factor: 8.989

9.  A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli.

Authors:  Xian C Rao; Shu Li; Jin C Hu; Xiao L Jin; Xiao M Hu; Jian J Huang; Zi J Chen; Jun M Zhu; Fu Q Hu
Journal:  Protein Expr Purif       Date:  2004-07       Impact factor: 1.650

Review 10.  SUMO fusion technology for difficult-to-express proteins.

Authors:  Tauseef R Butt; Suzanne C Edavettal; John P Hall; Michael R Mattern
Journal:  Protein Expr Purif       Date:  2005-04-09       Impact factor: 1.650

View more
  6 in total

1.  Production and characterization of hirudin variant-1 by SUMO fusion technology in E. coli.

Authors:  Wuguang Lu; Xueting Cai; Zhenghua Gu; Yuzheng Huang; Binbin Xia; Peng Cao
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

2.  High efficient expression of bioactive human BMP-14 in E. coli using SUMO fusion partner.

Authors:  Jian Feng Li; Xian Wei Cui; Hai Yan Ji; Ting Qiu; Xue Mei Ji; Ming Xian Du; Hai Tao Wu; Xing Zhou Xu; Shuang Quan Zhang
Journal:  Protein J       Date:  2011-12       Impact factor: 2.371

3.  Efficient biosynthesis of a Cecropin A-melittin mutant in Bacillus subtilis WB700.

Authors:  Shengyue Ji; Weili Li; Abdul Rasheed Baloch; Meng Wang; Hengxin Li; Binyun Cao; Hongfu Zhang
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

4.  Engineered endolysin-based "artilysins" for controlling the gram-negative pathogen Helicobacter pylori.

Authors:  Dengyuan Xu; Shanshan Zhao; Jun Dou; Xiaofeng Xu; Yanyan Zhi; Liangzhu Wen
Journal:  AMB Express       Date:  2021-04-28       Impact factor: 3.298

5.  Expression, Purification and Characterization of a Novel Hybrid Peptide CLP with Excellent Antibacterial Activity.

Authors:  Junhao Cheng; Marhaba Ahmat; Henan Guo; Xubiao Wei; Lulu Zhang; Qiang Cheng; Jing Zhang; Junyong Wang; Dayong Si; Yueping Zhang; Rijun Zhang
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

6.  Suppression of the toxicity of Bac7 (1-35), a bovine peptide antibiotic, and its production in E. coli.

Authors:  Yojiro Ishida; Masayori Inouye
Journal:  AMB Express       Date:  2016-03-02       Impact factor: 3.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.